XBiotech (XBIT) Stock: Buy, Sell, or Hold?
XBIT - XBiotech Inc
$2.20
0.00 (0.00%)
▲
5d:
-3.08%
30d:
-3.51%
90d:
-7.17%
WAIT
LOW Confidence
Analysis Updated: Sep 4, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When XBIT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: XBIT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: XBIT shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: XBIT is currently trading at $2.20, which is considered oversold relative to its 30-day fair value range of $2.23 to $2.33.
Technical Outlook: Technically, XBIT is in a strong downtrend. The price is currently testing key support at $2.19. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $18.00 (+718.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XBIT is in a strong downtrend. The price is currently testing key support at $2.19. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $18.00 (+718.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.23 -
$2.33
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 718.2% below Wall St target ($18.00)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.23 -
$2.33
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.19
Resistance Level
$2.33
Current Trend
Strong Downtrend
Technical data as of
Sep 4, 2026
Fundamental Context
Wall Street Target
$18.00
(+718.2%)
Revenue Growth (YoY)
-93.3%
Share & Embed Analysis
Last updated: September 06, 2026 10:35 PM ET
Data refreshes hourly during market hours. Next update: 11:35 PM
Data refreshes hourly during market hours. Next update: 11:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XBIT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 56 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 52 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 45 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 48 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 61 BUY |
